ATRAID regulates the action of nitrogen-containing bisphosphonates on bone

ATRAID regulates the action of nitrogen-containing bisphosphonates on bone

Copyright © 2020 The Authors, some rights reserved. Nitrogen-containing bisphosphonates (N-BPs), such as alendronate, are the most widely prescribed medications for diseases involving bone, with nearly 200 million prescriptions written annually. Recently, widespread use of N-BPs has been challenged...

Full description

Bibliographic Details
Format:	Article
Language:	English
Published:	American Association for the Advancement of Science (AAAS) 2021
Online Access:	https://hdl.handle.net/1721.1/133570

Similar Items

ATRAID regulates the action of nitrogen-containing bisphosphonates on bone
by: Sabatini, David
Published: (2022)

Functional characterization of all‐trans retinoic acid‐induced differentiation factor (ATRAID)
by: Roya Mehrasa, et al.
Published: (2023-10-01)

BONE AFFINITY DIFFERENCES OF NITROGEN-CONTAINING BISPHOSPHONATES PREDICTED BY IN VITRO BINDING TO CARBONATED APATITE
by: Ebetino, F, et al.
Published: (2004)

Molecular modeling of the bisphosphonates in farnesyl diphosphate synthase. potential new details of the precise biochemical mechanism of action of potent nitrogen containing bisphosphonates
by: Ebetino, F, et al.
Published: (2002)

The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
by: Kavanagh, K, et al.
Published: (2006)

The Successful Design Of A Novel Highly Potent Nitrogen-Containing Bisphosphonate With Lower Bone Affinity.
by: Ebetino, F, et al.
Published: (2013)

Non-Nitrogen-Containing Bisphosphonates Prevent Pyrophosphorylation of Exocytosis Proteins
by: Sahid, Muhammad N. A.
Published: (2022)

The mode of binding of nitrogen containing bisphosphonates in farnesyl pyrophosphate synthase
by: Ebetino, F, et al.
Published: (2007)

EFFECTIVENESS OF NITROGEN-CONTAINING BISPHOSPHONATES IN THE REGULATION OF MINERAL METABOLISM DISTURBANCES ASSOCIATED WITH ALIMENTARY OSTEOPOROSIS IN RATS
by: Komisarenko S. V., et al.
Published: (2015-08-01)

Molecular interactions of nitrogen-containing bisphosphonates within farnesyl diphosphate synthase
by: Ebetino, F, et al.
Published: (2005)

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
by: Nancollas, G, et al.
Published: (2006)

Bisphosphonates: Mechanisms of Action
by: Roelofs, A, et al.
Published: (2008)

Nitrogen-containing bisphosphonates induce apoptosis in human bone marrow-derived myeloma cells in vitro by inhibiting protein prenylation.
by: Gordon, S, et al.
Published: (1999)

Bisphosphonates and bone quality.
by: Pazianas, M, et al.
Published: (2014)

Molecular targets of the nitrogen containing bisphosphonates: the molecular pharmacology of prenyl synthase inhibition.
by: Dunford, J
Published: (2010)

Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates
by: Wyant, Gregory A, et al.
Published: (2020)

Stereochemical evidence of the mode of binding of nitrogen containing bisphosphonates in farnesyl diphosphate synthase
by: Ebetino, F, et al.
Published: (2007)

Analysis of the kinetic mechanism of inhibition of Farnesyl Pyrophosphate Synthase by nitrogen containing bisphosphonates.
by: Dunford, J, et al.
Published: (2006)

Investigations into the kinetic mechanism of inhibition of farnesyl diphosphate synthase by nitrogen containing bisphosphonates
by: Dunford, J, et al.
Published: (2006)

Molecular modeling of the bisphosphonates (BPs) in farnesyl diphosphate (FPP) synthase. Proposed new mechanism of inhibition by potent nitrogen containing bisphosphonates (NBPs).
by: Ebetino, F, et al.
Published: (2002)

Bisphosphonates: mode of action and pharmacology.
by: Russell, R
Published: (2007)

Kinetic analysis of conformational changes in farnesyl pyrophosphate synthase induced by nitrogen containing bisphosphonates
by: Dunford, J, et al.
Published: (2007)

Kinetic analysis of conformational changes in farnesyl pyrophosphate synthase induced by nitrogen containing bisphosphonates
by: Dunford, J, et al.
Published: (2007)

The interaction of sidechain nitrogen with active site threonine is not essential for inhibition of farnesyl pyrophosphate synthase by nitrogen containing bisphosphonates
by: Dunford, J, et al.
Published: (2008)

Nitrogen-Containing Bisphosphonates Downregulate Cathepsin K and Upregulate Annexin V in Osteoclasts Cultured In Vitro
by: Arturo Bautista-Carbajal, et al.
Published: (2023-01-01)

Bisphosphonates--mechanisms of action in multiple myeloma.
by: Shipman, C, et al.
Published: (2000)

Physiological and biological mechanisms of bisphosphonate action
by: Duan, X
Published: (2011)

The Role of Active Site Threonine 201 in the Inhibition of Farnesyl Pyrophosphate Synthase by Nitrogen Containing Bisphosphonates
by: Dunford, J, et al.
Published: (2008)

Nitrogen-containing bisphosphonates and prediction of their clinical potencies: Dissociation of target enzyme- and hydroxyapatite-binding affinities
by: Xia, Z, et al.
Published: (2007)

New anti-candida active nitrogen-containing bisphosphonates as inhibitors of farnesyl pyrophosphate synthase Candida albicans
by: L. O. Metelytsia, et al.
Published: (2019-05-01)

Molecular modeling comparison of nitrogen-containing bisphosphonates of varying potency co-crystalized in farnesyl diphosphate synthase
by: Ebetino, F, et al.
Published: (2006)

Molecular modeling comparison of nitrogen-containing bisphosphonates of varying potency co-crystalized in farnesyl diphosphate synthase
by: Ebetino, F, et al.
Published: (2006)

Evidence for the involvement of the threonine 201 side-chain in the interaction of nitrogen-containing bisphosphonates with farnesyl pyrophosphate synthase
by: Kwassi, A, et al.
Published: (2009)

Predicting pharmacological potencies of nitrogen-containing bisphosphonates; novel methods dissociate enzyme- and hydroxyapatite-binding affinities
by: Xia, Z, et al.
Published: (2007)

Structure activity relationships of nitrogen containing bisphosphonates which induce conformational changes in farnesyl pyrophosphate synthase
by: Dunford, J, et al.
Published: (2008)

Denosumab and bisphosphonates: different mechanisms of action and effects.
by: Baron, R, et al.
Published: (2011)

The pharmacology of bisphosphonates and new insights into their mechanisms of action.
by: Russell, R, et al.
Published: (1999)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
by: Croucher, P, et al.
Published: (2003)

Use of bisphosphonates in bone pathology – benefits and risks
by: Dinu Antonescu, et al.
Published: (2023-03-01)

Design and Biological Evaluation of Delivery Systems Containing Bisphosphonates
by: Blessing Aderibigbe, et al.
Published: (2016-12-01)